Shanmugam Muthusamy, head of R&D and COO of Novitium Ops at ANI Pharmaceuticals ($ANIP), sold about $17.9 million in company shares across five open market transactions over the past year. His most recent sale occurred on August 21, 2025. These sales rank him 730th among 11,678 individual insiders by total value sold, above the average of $8.6 million per insider and 6.4 transactions. He made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 26, 2026 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | A | Common Stock | 11116 | $77.15 | 537,976.0000 | 23,076,000 | 2.11% | 0.05% |
| Feb. 11, 2026 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | F | Common Stock | 2898 | $76.25 | 526,860.0000 | 23,076,000 | 0.55% | 0.01% |
| Aug. 20, 2025 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 47012 | $90.27 | 582,496.0000 | 22,322,000 | 7.47% | 0.21% |
| Aug. 21, 2025 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 52988 | $90.44 | 529,508.0000 | 22,322,000 | 9.10% | 0.24% |
| Aug. 14, 2025 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 47010 | $89.48 | 682,498.0000 | 22,322,000 | 6.44% | 0.21% |
| Aug. 15, 2025 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 52990 | $87.15 | 629,508.0000 | 22,322,000 | 7.76% | 0.24% |
| May 9, 2025 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 700 | $76.83 | 729,508.0000 | 21,538,000 | 0.10% | 0.00% |
| Feb. 12, 2025 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | A | Common Stock | 9574 | $0.00 | 730,208.0000 | 21,538,000 | 1.33% | 0.04% |
| Feb. 12, 2025 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | A | Common Stock | 14362 | $0.00 | 720,634.0000 | 21,538,000 | 2.03% | 0.07% |
| July 18, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 2743 | $62.00 | 706,272.0000 | 21,476,000 | 0.39% | 0.01% |
| July 16, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 22000 | $64.27 | 723,272.0000 | 21,476,000 | 2.95% | 0.10% |
| July 17, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 14257 | $63.16 | 709,015.0000 | 21,476,000 | 1.97% | 0.07% |
| July 15, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 11000 | $63.38 | 745,272.0000 | 21,476,000 | 1.45% | 0.05% |
| June 21, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 20000 | $58.90 | 756,272.0000 | 20,731,000 | 2.58% | 0.10% |
| June 20, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 11447 | $59.86 | 776,272.0000 | 20,731,000 | 1.45% | 0.06% |
| June 17, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 7946 | $61.41 | 798,326.0000 | 20,731,000 | 0.99% | 0.04% |
| June 18, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 10607 | $60.76 | 787,719.0000 | 20,731,000 | 1.33% | 0.05% |
| May 20, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 12855 | $61.81 | 806,272.0000 | 20,731,000 | 1.57% | 0.06% |
| May 17, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 5836 | $62.09 | 819,127.0000 | 20,731,000 | 0.71% | 0.03% |
| May 15, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 14850 | $65.86 | 841,422.0000 | 20,731,000 | 1.73% | 0.07% |
| May 16, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 16459 | $63.84 | 824,963.0000 | 20,731,000 | 1.96% | 0.08% |
| April 19, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 16809 | $65.17 | 856,272.0000 | 20,731,000 | 1.93% | 0.08% |
| April 18, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 10423 | $64.98 | 873,081.0000 | 20,731,000 | 1.18% | 0.05% |
| April 16, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 5834 | $66.20 | 893,024.0000 | 20,731,000 | 0.65% | 0.03% |
| April 17, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 9520 | $65.40 | 883,504.0000 | 20,731,000 | 1.07% | 0.05% |
| April 15, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 7414 | $66.33 | 898,858.0000 | 20,731,000 | 0.82% | 0.04% |
| March 8, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 10000 | $67.17 | 906,272.0000 | 20,731,000 | 1.09% | 0.05% |
| March 5, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 10093 | $65.35 | 946,179.0000 | 20,731,000 | 1.06% | 0.05% |
| March 6, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 14822 | $65.47 | 931,357.0000 | 20,731,000 | 1.57% | 0.07% |
| March 7, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 15085 | $66.35 | 916,272.0000 | 20,731,000 | 1.62% | 0.07% |
| Feb. 29, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | F | Common Stock | 1122 | $67.67 | 956,272.0000 | 20,731,000 | 0.12% | 0.01% |
| Feb. 14, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | A | Common Stock | 13421 | $0.00 | 948,448.0000 | 20,731,000 | 1.44% | 0.06% |
| Feb. 14, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | A | Common Stock | 8946 | $0.00 | 957,394.0000 | 20,731,000 | 0.94% | 0.04% |
| Jan. 22, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 5692 | $55.95 | 950,027.0000 | 20,731,000 | 0.60% | 0.03% |
| Jan. 23, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 15000 | $56.44 | 935,027.0000 | 20,731,000 | 1.58% | 0.07% |
| Jan. 19, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 4524 | $55.57 | 955,719.0000 | 20,731,000 | 0.47% | 0.02% |
| Jan. 18, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 9784 | $55.30 | 960,243.0000 | 20,731,000 | 1.01% | 0.05% |
| Jan. 17, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 10000 | $55.11 | 970,027.0000 | 20,731,000 | 1.02% | 0.05% |
| Jan. 16, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 5000 | $55.63 | 980,027.0000 | 20,731,000 | 0.51% | 0.02% |
| Dec. 18, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 13026 | $52.44 | 1,010,027.0000 | 17,644,000 | 1.27% | 0.07% |
| Dec. 15, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 11974 | $52.44 | 1,023,053.0000 | 17,644,000 | 1.16% | 0.07% |
| Dec. 19, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 25000 | $52.65 | 985,027.0000 | 17,644,000 | 2.48% | 0.14% |
| Nov. 15, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 7647 | $53.64 | 1,002,068.0000 | 17,644,000 | 0.76% | 0.04% |
| Nov. 17, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 13000 | $51.00 | 1,035,027.0000 | 17,644,000 | 1.24% | 0.07% |
| Nov. 14, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 22905 | $53.17 | 1,009,715.0000 | 17,644,000 | 2.22% | 0.13% |
| Nov. 16, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 6448 | $51.66 | 995,620.0000 | 17,644,000 | 0.64% | 0.04% |
| Nov. 15, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 7647 | $53.64 | 1,055,285.0000 | 17,644,000 | 0.72% | 0.04% |
| Nov. 16, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 6448 | $51.66 | 1,048,837.0000 | 17,644,000 | 0.61% | 0.04% |
| Nov. 14, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 22095 | $53.17 | 1,062,932.0000 | 17,644,000 | 2.04% | 0.13% |
| Oct. 17, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 8758 | $58.53 | 1,101,269.0000 | 17,644,000 | 0.79% | 0.05% |
| Oct. 19, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 10000 | $57.06 | 1,085,027.0000 | 17,644,000 | 0.91% | 0.06% |
| Oct. 18, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 6242 | $57.78 | 1,095,027.0000 | 17,644,000 | 0.57% | 0.04% |
| Oct. 16, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 13063 | $58.31 | 1,110,027.0000 | 17,644,000 | 1.16% | 0.07% |
| Oct. 13, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 11937 | $57.58 | 1,123,090.0000 | 17,644,000 | 1.05% | 0.07% |
| Sept. 19, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 25333 | $61.23 | 1,135,027.0000 | 17,644,000 | 2.18% | 0.14% |
| Sept. 15, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 16242 | $62.81 | 1,168,785.0000 | 17,644,000 | 1.37% | 0.09% |
| Sept. 18, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 8425 | $61.64 | 1,160,360.0000 | 17,644,000 | 0.72% | 0.05% |
| Aug. 29, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 25000 | $63.37 | 1,185,027.0000 | 17,644,000 | 2.07% | 0.14% |
| Aug. 28, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 25000 | $63.06 | 1,210,027.0000 | 17,644,000 | 2.02% | 0.14% |
| Aug. 14, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 27890 | $61.15 | 1,257,137.0000 | 17,644,000 | 2.17% | 0.16% |
| Aug. 15, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 22110 | $61.60 | 1,235,027.0000 | 17,644,000 | 1.76% | 0.13% |
| July 20, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 6000 | $51.52 | 1,296,527.0000 | 17,644,000 | 0.46% | 0.03% |
| July 19, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 5969 | $51.48 | 1,302,527.0000 | 17,644,000 | 0.46% | 0.03% |
| July 21, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 11500 | $52.56 | 1,285,027.0000 | 17,644,000 | 0.89% | 0.07% |
| July 14, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 10000 | $50.43 | 1,325,027.0000 | 17,644,000 | 0.75% | 0.06% |
| July 17, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 9831 | $51.06 | 1,315,196.0000 | 17,644,000 | 0.74% | 0.06% |
| July 18, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 6700 | $51.84 | 1,308,496.0000 | 17,644,000 | 0.51% | 0.04% |
| June 21, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 11843 | $51.95 | 1,358,527.0000 | 17,644,000 | 0.86% | 0.07% |
| June 22, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 13500 | $51.38 | 1,345,027.0000 | 17,644,000 | 0.99% | 0.08% |
| June 23, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 10000 | $51.49 | 1,335,027.0000 | 17,644,000 | 0.74% | 0.06% |
| June 20, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 14657 | $51.93 | 1,370,370.0000 | 17,644,000 | 1.06% | 0.08% |
| June 22, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 13500 | $51.38 | 1,345,027.0000 | 17,644,000 | 0.99% | 0.08% |
| June 20, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 14657 | $51.93 | 1,370,370.0000 | 17,644,000 | 1.06% | 0.08% |
| June 21, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | S | Common Stock | 11843 | $51.95 | 1,358,527.0000 | 17,644,000 | 0.86% | 0.07% |
| Feb. 28, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | A | Common Stock | 17369 | $0.00 | 1,373,449.0000 | 17,644,000 | 1.28% | 0.10% |
| Feb. 28, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | A | Common Stock | 11578 | $0.00 | 1,385,027.0000 | 17,644,000 | 0.84% | 0.07% |